Search

everythinglearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

XEDAR triggers a specific signaling pathway in cells.

Type II keratins are uniquely phosphorylated during stress and mitosis, affecting their structure and function.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

YAP and TAZ proteins control skin cell growth and repair.

Activated ras can protect kidney cells from a certain substance that causes cell death.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Topical IKKα inhibitors may help prevent CCS tumours.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

Akt2 protein is essential for normal cell division in early mouse embryos.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.